JPRN-UMIN000052672
Not yet recruiting
未知
Monitoring of Adverse Event for Anticancer Drugs Using Mobile Healthcare - Monitoring of Adverse Event for Anticancer Drugs Using Mobile Healthcare
ConditionsCancers
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cancers
- Sponsor
- Hamamatsu University School of Medicine
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. patients who have received no anticancer therapy but only supportive or palliative therapy 2\. patients with a prognosis predicted to be less than 6 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Responsible Side Effects Management in OncologyPharmacovigilanceOncologyAntineoplastic TreatmentNCT04623437University Hospital "Sestre Milosrdnice"267
Not yet recruiting
Not Applicable
Abnormal Drug Reaction Surveillance in Patients Receiving Chemotherapy at a State-Level Cancer InstituteHealth Condition 1: D499- Neoplasm of unspecified behavior of unspecified siteHealth Condition 2: C00-D49- NeoplasmsCTRI/2024/03/064191ot Available
Not yet recruiting
Not Applicable
Monitoring of Adverse Drug reactionsHealth Condition 1: 4- Measurement and MonitoringCTRI/2023/10/058715Bhagyashree S
Not yet recruiting
Not Applicable
Clinical , Economic and Humanistic Outcomes of Suspected Adverse Drug Reactions among In-Patients in a Tertiary Care HospitalHealth Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedCTRI/2019/04/018776Shatavisa Mukherjee
Not yet recruiting
Not Applicable
Monitoring Side Effects of Tuberculosis and HIV Medications: Understanding side effects in Patients on ATT and ART for Better TreatmentCTRI/2024/07/069753Dr Puneet Paliwal